A&O Shearman demonstrates capabilities in both life sciences and tech patents and has a strong track record in all major litigation venues. The team is particularly strong on Hatch-Waxman on both the brand and generic side. The team is led by New York’s
Elizabeth Holland, a first-chair trial lawyer sought after by pharma, biotech and medical device companies. In Boston,
John Bennett specializes in Hatch-Waxman and BPCIA cases.
William James, in Washington DC, is another key Hatch-Waxman specialist who also focuses on IPR and appellate proceedings.